1-2 of 2
Hidetoshi Eguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma

Keiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, Keisuke Toya, Tsuyoshi Takahashi, Takashi Matsunaga, Minoru Fujimoto, Sunao Uemura, Tsutomu Namikawa, Ichiro Murakami, Shogo Kobayashi, Hidetoshi Eguchi, Yuichiro Doki, Kazuhiro Hanazaki, Tetsuji Naka
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (9): 1713–1722.
https://doi.org/10.1158/1535-7163.MCT-21-0015
Published: 01 September 2021
View article titled, Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma
Open the PDF for Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma in another window
Includes: Supplementary data
Journal Articles

Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth

Takeshi Harada, Shinji Matsumoto, Suguru Hirota, Hirokazu Kimura, Shinsuke Fujii, Yuuya Kasahara, Hidetoshi Gon, Toshihiko Yoshida, Tomoo Itoh, Naotsugu Haraguchi, Tsunekazu Mizushima, Takehiro Noda, Hidetoshi Eguchi, Satoshi Nojima, Eiichi Morii, Takumi Fukumoto, Satoshi Obika, Akira Kikuchi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 602–612.
https://doi.org/10.1158/1535-7163.MCT-18-0824
Published: 01 March 2019
View article titled, Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth
Open the PDF for Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth in another window
Includes: Supplementary data